AEYE INC (LIDR)

US0081832042 - Common Stock

1.03  +0.04 (+3.73%)

After market: 1.05 +0.02 (+1.94%)

Fundamental Rating

3

Taking everything into account, LIDR scores 3 out of 10 in our fundamental rating. LIDR was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. LIDR has a great financial health rating, but its profitability evaluates not so good. LIDR is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

LIDR had negative earnings in the past year.
In the past year LIDR has reported a negative cash flow from operations.
LIDR had negative earnings in each of the past 5 years.
LIDR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

LIDR has a Return On Assets of -160.41%. This is amonst the worse of the industry: LIDR underperforms 94.44% of its industry peers.
Looking at the Return On Equity, with a value of -300.21%, LIDR is doing worse than 92.86% of the companies in the same industry.
Industry RankSector Rank
ROA -160.41%
ROE -300.21%
ROIC N/A
ROA(3y)-89.79%
ROA(5y)-101.53%
ROE(3y)-147.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LIDR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

LIDR does not have a ROIC to compare to the WACC, probably because it is not profitable.
LIDR has less shares outstanding than it did 1 year ago.
LIDR has less shares outstanding than it did 5 years ago.
There is no outstanding debt for LIDR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

LIDR has an Altman-Z score of -12.59. This is a bad value and indicates that LIDR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LIDR (-12.59) is worse than 89.68% of its industry peers.
LIDR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.59
ROIC/WACCN/A
WACC7.89%

2.3 Liquidity

LIDR has a Current Ratio of 3.96. This indicates that LIDR is financially healthy and has no problem in meeting its short term obligations.
LIDR has a better Current ratio (3.96) than 73.02% of its industry peers.
A Quick Ratio of 3.91 indicates that LIDR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.91, LIDR belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.96
Quick Ratio 3.91

4

3. Growth

3.1 Past

The earnings per share for LIDR have decreased strongly by -60.64% in the last year.
Looking at the last year, LIDR shows a very negative growth in Revenue. The Revenue has decreased by -59.81% in the last year.
The Revenue has been decreasing by -2.51% on average over the past years.
EPS 1Y (TTM)-60.64%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q75.56%
Revenue 1Y (TTM)-59.81%
Revenue growth 3Y-2.51%
Revenue growth 5YN/A
Revenue growth Q2Q-93.67%

3.2 Future

Based on estimates for the next years, LIDR will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.24% on average per year.
LIDR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 264.87% yearly.
EPS Next Y28.98%
EPS Next 2Y13.35%
EPS Next 3Y16.89%
EPS Next 5Y18.24%
Revenue Next Year13.33%
Revenue Next 2Y205.51%
Revenue Next 3Y249.43%
Revenue Next 5Y264.87%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LIDR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LIDR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LIDR's earnings are expected to grow with 16.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.35%
EPS Next 3Y16.89%

0

5. Dividend

5.1 Amount

No dividends for LIDR!.
Industry RankSector Rank
Dividend Yield N/A

AEYE INC

NASDAQ:LIDR (5/2/2024, 7:04:36 PM)

After market: 1.05 +0.02 (+1.94%)

1.03

+0.04 (+3.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.70M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -160.41%
ROE -300.21%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.96
Quick Ratio 3.91
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-60.64%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y28.98%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-59.81%
Revenue growth 3Y-2.51%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y